|
|
|
| home > white papers > Changing Structural Landscape for Comparator Drug Supply - ADAllen Pharma |
|
|
 WHITE PAPERS |
|
ADAllen Pharma
|
|
Changing Structural Landscape for Comparator Drug Supply
|
|
TransCelerate BioPharma is focused on advancing innovation in R&D,
identifying and solving common R&D challenges and further improving
patient safety, with the goal of delivering more high quality medicines
to patients. In 2013, they announced its Clinical Trial Comparator
Network initiative to show a mutual commitment to offer secure and rapid
supply of comparator drug products. The aim of this article is to
unpack the section on 'Comparator Drugs' and analyse the rationale for
attempting to achieve their objectives.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Charles River Laboratories Announces Extended Relationship with The Michael J. Fox Foundation
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL)
today announced an extension of its long-standing collaboration with The
Michael J. Fox Foundation for Parkinson’s Research (MJFF), a leading
organization working to support the diagnosis and treatment of
Parkinson’s disease (PD). Since 2011, Charles River and MJFF have worked
together to accelerate the discovery of therapies for PD. This latest
extension includes grants from MJFF to support two projects:
More info >> |
|
 |
White Papers |
 |
|
The Impact of Components on Drug Quality and Risk Mitigation
West Pharmaceutical Services, Inc.
Expectations for quality by regulatory agencies are increasing at a very fast pace, especially for prefilled drug delivery formats, thanks to increased focus on reducing risk to patient safety. The trend has resulted in delays for new drug applications, more recalls of marketed products and even drug shortages if the container system and drug contents are suspect for quality issues. The pharmaceutical market is now requiring manufacturers of containers and components to meet new expectations with a quality culture and very high product reliability. The need to bridge the gap and provide superior quality products has been a driver for manufacturing technology investments, more robust control strategies and the introduction of next generation elastomer components.
More info >> |
|
 |
Industry Events |
 |
On Helix 2018
10-11 July 2018, The Cambridge Building, Babraham Research Campus
ON Helix is a two-day event aimed at informing delegates
of how to turn early stage inventions and ideas into innovative health treatments
(new medicines, novel biomarkers, useful medical devices or improved medical
practices).
More info >> |
|
|
|
